ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Immuno-Oncology Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-20U9090
Home | Market Reports | Health| Nursing
Global Immuno Oncology Market Size Status and Forecast 2022
BUY CHAPTERS

Global Immuno-Oncology Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-20U9090
Report
June 2025
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol–Myers Squibb
Merck& Co. Inc
Roche
Astrazeneca plc
Sanofi
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc
Merck KGaA

Immuno-Oncology Market Size

In 2024, the global market size of Immuno-Oncology was estimated to be worth US$ 57510 million and is forecast to reach approximately US$ 150070 million by 2031 with a CAGR of 14.9% during the forecast period 2025-2031.

Immuno-Oncology Market

Immuno-Oncology Market

Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body"s own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
The industry"s leading producers are Bristol-Myers Squibb, Merck & Co and Roche AG, with revenues of 27.89%, 22.10% and 20.85%, respectively, in 2019.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Immuno-Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-Oncology.
The Immuno-Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immuno-Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immuno-Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Immuno-Oncology Market Report

Report Metric Details
Report Name Immuno-Oncology Market
CAGR 14.9%
Segment by Type
  • Immune Checkpoint Inhibitors
  • Cytokine-Based Immunotherapy
  • Cancer Vaccines
  • CAR-T Cell Therapy
  • Others
Segment by Application
  • Hospitals
  • Drugstores
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bristol-Myers Squibb, Merck & Co., Inc., Roche AG, AstraZeneca, Plc, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Immuno-Oncology in global and regional level.
  • Chapter 3: Detailed analysis of Immuno-Oncology company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immuno-Oncology revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

Who are the main players in the Immuno-Oncology Market report?

Ans: The main players in the Immuno-Oncology Market are Bristol-Myers Squibb, Merck & Co., Inc., Roche AG, AstraZeneca, Plc, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA

What are the Application segmentation covered in the Immuno-Oncology Market report?

Ans: The Applications covered in the Immuno-Oncology Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the Immuno-Oncology Market report?

Ans: The Types covered in the Immuno-Oncology Market report are Immune Checkpoint Inhibitors, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy, Others

1 Study Coverage
1.1 Immuno-Oncology Product Introduction
1.2 Market by Type
1.2.1 Global Immuno-Oncology Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Cytokine-Based Immunotherapy
1.2.4 Cancer Vaccines
1.2.5 CAR-T Cell Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Immuno-Oncology Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Immuno-Oncology Market Size Estimates and Forecasts
2.2 Immuno-Oncology Market Size by Region: 2024 Versus 2031
2.2.1 Global Immuno-Oncology Revenue by Region: 2020-2025
2.2.2 Global Immuno-Oncology Revenue Forecast by Region (2026-2031)
2.2.3 Global Immuno-Oncology Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Immuno-Oncology Revenue by Type (2020-2031)
3.1.2 Global Immuno-Oncology Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Immuno-Oncology Revenue by Application (2020-2031)
3.2.2 Global Immuno-Oncology Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Immune Checkpoint Inhibitors of Immuno-Oncology Revenue Market Share by Application
3.3.2 Cytokine-Based Immunotherapy of Immuno-Oncology Revenue Market Share by Application
3.3.3 Cancer Vaccines of Immuno-Oncology Revenue Market Share by Application
3.3.4 CAR-T Cell Therapy of Immuno-Oncology Revenue Market Share by Application
3.3.5 Others of Immuno-Oncology Revenue Market Share by Application
4 Global Immuno-Oncology by Company
4.1 Global Immuno-Oncology Revenue by Company (2020-2025)
4.2 Global Immuno-Oncology Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Immuno-Oncology Companies around the World: Ranking by Revenue
4.3.2 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Immuno-Oncology Companies Headquarters & Product Type
4.4.1 Global Immuno-Oncology Companies Headquarters
4.4.2 Date of International Companies Enter into Immuno-Oncology Market
4.4.3 Global Immuno-Oncology Companies Product & Service
4.4.4 Immune Checkpoint Inhibitors Revenue Market Share of Immuno-Oncology by Company
4.4.5 Cytokine-Based Immunotherapy Revenue Market Share of Immuno-Oncology by Company
4.4.6 Cancer Vaccines Revenue Market Share of Immuno-Oncology by Company
4.4.7 CAR-T Cell Therapy Revenue Market Share of Immuno-Oncology by Company
4.4.8 Others Revenue Market Share of Immuno-Oncology by Company
4.5 Global Immuno-Oncology Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Bristol-Myers Squibb
5.1.1 Bristol-Myers Squibb Corporation Information
5.1.2 Bristol-Myers Squibb Description, Business Overview
5.1.3 Bristol-Myers Squibb Immuno-Oncology Products Offered
5.1.4 Bristol-Myers Squibb Immuno-Oncology Revenue and Gross Margin (2020-2025)
5.1.5 Bristol-Myers Squibb Immuno-Oncology Revenue by Product in 2024
5.1.6 Bristol-Myers Squibb Immuno-Oncology Revenue by Application in 2024
5.1.7 Bristol-Myers Squibb Immuno-Oncology Revenue by Geographic Area in 2024
5.1.8 Bristol-Myers Squibb Recent Developments
5.2 Merck & Co., Inc.
5.2.1 Merck & Co., Inc. Corporation Information
5.2.2 Merck & Co., Inc. Description, Business Overview
5.2.3 Merck & Co., Inc. Immuno-Oncology Products Offered
5.2.4 Merck & Co., Inc. Immuno-Oncology Revenue and Gross Margin (2020-2025)
5.2.5 Merck & Co., Inc. Immuno-Oncology Revenue by Product in 2024
5.2.6 Merck & Co., Inc. Immuno-Oncology Revenue by Application in 2024
5.2.7 Merck & Co., Inc. Immuno-Oncology Revenue by Geographic Area in 2024
5.2.8 Merck & Co., Inc. Recent Developments
5.3 Roche AG
5.3.1 Roche AG Corporation Information
5.3.2 Roche AG Description, Business Overview
5.3.3 Roche AG Immuno-Oncology Products Offered
5.3.4 Roche AG Immuno-Oncology Revenue and Gross Margin (2020-2025)
5.3.5 Roche AG Immuno-Oncology Revenue by Product in 2024
5.3.6 Roche AG Immuno-Oncology Revenue by Application in 2024
5.3.7 Roche AG Immuno-Oncology Revenue by Geographic Area in 2024
5.3.8 Roche AG Recent Developments
5.4 AstraZeneca, Plc
5.4.1 AstraZeneca, Plc Corporation Information
5.4.2 AstraZeneca, Plc Description, Business Overview
5.4.3 AstraZeneca, Plc Immuno-Oncology Products Offered
5.4.4 AstraZeneca, Plc Immuno-Oncology Revenue and Gross Margin (2020-2025)
5.4.5 AstraZeneca, Plc Immuno-Oncology Revenue by Product in 2024
5.4.6 AstraZeneca, Plc Immuno-Oncology Revenue by Application in 2024
5.4.7 AstraZeneca, Plc Immuno-Oncology Revenue by Geographic Area in 2024
5.4.8 AstraZeneca, Plc Recent Developments
5.5 Sanofi S.A.
5.5.1 Sanofi S.A. Corporation Information
5.5.2 Sanofi S.A. Description, Business Overview
5.5.3 Sanofi S.A. Immuno-Oncology Products Offered
5.5.4 Sanofi S.A. Immuno-Oncology Revenue and Gross Margin (2020-2025)
5.5.5 Sanofi S.A. Immuno-Oncology Revenue by Product in 2024
5.5.6 Sanofi S.A. Immuno-Oncology Revenue by Application in 2024
5.5.7 Sanofi S.A. Immuno-Oncology Revenue by Geographic Area in 2024
5.5.8 Sanofi S.A. Recent Developments
5.6 Dendreon Pharmaceuticals
5.6.1 Dendreon Pharmaceuticals Corporation Information
5.6.2 Dendreon Pharmaceuticals Description, Business Overview
5.6.3 Dendreon Pharmaceuticals Immuno-Oncology Products Offered
5.6.4 Dendreon Pharmaceuticals Immuno-Oncology Revenue and Gross Margin (2020-2025)
5.6.5 Dendreon Pharmaceuticals Immuno-Oncology Revenue by Product in 2024
5.6.6 Dendreon Pharmaceuticals Immuno-Oncology Revenue by Application in 2024
5.6.7 Dendreon Pharmaceuticals Immuno-Oncology Revenue by Geographic Area in 2024
5.6.8 Dendreon Pharmaceuticals Recent Developments
5.7 Novartis
5.7.1 Novartis Corporation Information
5.7.2 Novartis Description, Business Overview
5.7.3 Novartis Immuno-Oncology Products Offered
5.7.4 Novartis Immuno-Oncology Revenue and Gross Margin (2020-2025)
5.7.5 Novartis Immuno-Oncology Revenue by Product in 2024
5.7.6 Novartis Immuno-Oncology Revenue by Application in 2024
5.7.7 Novartis Immuno-Oncology Revenue by Geographic Area in 2024
5.7.8 Novartis Recent Developments
5.8 Gilead Sciences Inc.
5.8.1 Gilead Sciences Inc. Corporation Information
5.8.2 Gilead Sciences Inc. Description, Business Overview
5.8.3 Gilead Sciences Inc. Immuno-Oncology Products Offered
5.8.4 Gilead Sciences Inc. Immuno-Oncology Revenue and Gross Margin (2020-2025)
5.8.5 Gilead Sciences Inc. Immuno-Oncology Revenue by Product in 2024
5.8.6 Gilead Sciences Inc. Immuno-Oncology Revenue by Application in 2024
5.8.7 Gilead Sciences Inc. Immuno-Oncology Revenue by Geographic Area in 2024
5.8.8 Gilead Sciences Inc. Recent Developments
5.9 Merck KGaA
5.9.1 Merck KGaA Corporation Information
5.9.2 Merck KGaA Description, Business Overview
5.9.3 Merck KGaA Immuno-Oncology Products Offered
5.9.4 Merck KGaA Immuno-Oncology Revenue and Gross Margin (2020-2025)
5.9.5 Merck KGaA Immuno-Oncology Revenue by Product in 2024
5.9.6 Merck KGaA Immuno-Oncology Revenue by Application in 2024
5.9.7 Merck KGaA Immuno-Oncology Revenue by Geographic Area in 2024
5.9.8 Merck KGaA Recent Developments
6 North America
6.1 North America Immuno-Oncology Market Size YoY Growth 2020-2031
6.2 North America Immuno-Oncology Market Facts & Figures by Country (2020-2031)
6.3 North America Immuno-Oncology Revenue by Type (2020-2025)
6.4 North America Immuno-Oncology Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Immuno-Oncology Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Immuno-Oncology Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Immuno-Oncology Revenue by Type (2020-2025)
7.4 Asia-Pacific Immuno-Oncology Revenue by Application (2020-2025)
8 Europe
8.1 Europe Immuno-Oncology Market Size YoY Growth 2020-2031
8.2 Europe Immuno-Oncology Market Facts & Figures by Country (2020-2031)
8.3 Europe Immuno-Oncology Revenue by Type (2020-2025)
8.4 Europe Immuno-Oncology Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Immuno-Oncology Market Size YoY Growth 2020-2031
9.2 Latin America Immuno-Oncology Market Facts & Figures by Country (2020-2031)
9.3 Latin America Immuno-Oncology Revenue by Type (2020-2025)
9.4 Latin America Immuno-Oncology Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Immuno-Oncology Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Immuno-Oncology Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Immuno-Oncology Revenue by Type (2020-2025)
10.4 Middle East and Africa Immuno-Oncology Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Immuno-Oncology Supply Chain Analysis
11.2 Immuno-Oncology Key Raw Materials and Upstream Suppliers
11.3 Immuno-Oncology Clients Analysis
11.4 Immuno-Oncology Sales Channel and Sales Model Analysis
11.4.1 Immuno-Oncology Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Immuno-Oncology Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Immuno-Oncology Distributors
12 Immuno-Oncology Market Dynamics
12.1 Immuno-Oncology Industry Trends
12.2 Immuno-Oncology Market Drivers
12.3 Immuno-Oncology Market Challenges
12.4 Immuno-Oncology Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Bristol–Myers Squibb
Merck& Co. Inc
Roche
Astrazeneca plc
Sanofi
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc
Merck KGaA
List of Tables
 Table 1. Global Immuno-Oncology Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Immuno-Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Immuno-Oncology Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Immuno-Oncology Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Immuno-Oncology Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Immuno-Oncology Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Immuno-Oncology Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Immuno-Oncology Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Immuno-Oncology Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Immuno-Oncology Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Immuno-Oncology Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Immuno-Oncology Players by Revenue (US$ Million) in 2024
 Table 13. Global Immuno-Oncology Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Immuno-Oncology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2024)
 Table 15. Global Immuno-Oncology Companies Headquarters
 Table 16. Date of International Companies Enter into Immuno-Oncology Market
 Table 17. Global Immuno-Oncology Companies Product & Service
 Table 18. Global Immuno-Oncology Mergers & Acquisitions, Expansion Plans
 Table 19. Bristol-Myers Squibb Corporation Information
 Table 20. Bristol-Myers Squibb Description and Business Overview
 Table 21. Bristol-Myers Squibb Immuno-Oncology Product
 Table 22. Bristol-Myers Squibb Immuno-Oncology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Bristol-Myers Squibb Revenue Proportion of Immuno-Oncology by Product in 2024
 Table 24. Bristol-Myers Squibb Revenue Proportion of Immuno-Oncology by Application in 2024
 Table 25. Bristol-Myers Squibb Revenue Proportion of Immuno-Oncology by Geographic Area in 2024
 Table 26. Bristol-Myers Squibb Recent Developments
 Table 27. Merck & Co., Inc. Corporation Information
 Table 28. Merck & Co., Inc. Description and Business Overview
 Table 29. Merck & Co., Inc. Immuno-Oncology Product
 Table 30. Merck & Co., Inc. Immuno-Oncology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Merck & Co., Inc. Revenue Proportion of Immuno-Oncology by Product in 2024
 Table 32. Merck & Co., Inc. Revenue Proportion of Immuno-Oncology by Application in 2024
 Table 33. Merck & Co., Inc. Revenue Proportion of Immuno-Oncology by Geographic Area in 2024
 Table 34. Merck & Co., Inc. Recent Developments
 Table 35. Roche AG Corporation Information
 Table 36. Roche AG Description and Business Overview
 Table 37. Roche AG Immuno-Oncology Product
 Table 38. Roche AG Immuno-Oncology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Roche AG Revenue Proportion of Immuno-Oncology by Product in 2024
 Table 40. Roche AG Revenue Proportion of Immuno-Oncology by Application in 2024
 Table 41. Roche AG Revenue Proportion of Immuno-Oncology by Geographic Area in 2024
 Table 42. Roche AG Recent Developments
 Table 43. AstraZeneca, Plc Corporation Information
 Table 44. AstraZeneca, Plc Description and Business Overview
 Table 45. AstraZeneca, Plc Immuno-Oncology Product
 Table 46. AstraZeneca, Plc Immuno-Oncology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. AstraZeneca, Plc Revenue Proportion of Immuno-Oncology by Product in 2024
 Table 48. AstraZeneca, Plc Revenue Proportion of Immuno-Oncology by Application in 2024
 Table 49. AstraZeneca, Plc Revenue Proportion of Immuno-Oncology by Geographic Area in 2024
 Table 50. AstraZeneca, Plc Recent Developments
 Table 51. Sanofi S.A. Corporation Information
 Table 52. Sanofi S.A. Description and Business Overview
 Table 53. Sanofi S.A. Immuno-Oncology Product
 Table 54. Sanofi S.A. Immuno-Oncology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Sanofi S.A. Revenue Proportion of Immuno-Oncology by Product in 2024
 Table 56. Sanofi S.A. Revenue Proportion of Immuno-Oncology by Application in 2024
 Table 57. Sanofi S.A. Revenue Proportion of Immuno-Oncology by Geographic Area in 2024
 Table 58. Sanofi S.A. Recent Developments
 Table 59. Dendreon Pharmaceuticals Corporation Information
 Table 60. Dendreon Pharmaceuticals Description and Business Overview
 Table 61. Dendreon Pharmaceuticals Immuno-Oncology Product
 Table 62. Dendreon Pharmaceuticals Immuno-Oncology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Dendreon Pharmaceuticals Revenue Proportion of Immuno-Oncology by Product in 2024
 Table 64. Dendreon Pharmaceuticals Revenue Proportion of Immuno-Oncology by Application in 2024
 Table 65. Dendreon Pharmaceuticals Revenue Proportion of Immuno-Oncology by Geographic Area in 2024
 Table 66. Dendreon Pharmaceuticals Recent Developments
 Table 67. Novartis Corporation Information
 Table 68. Novartis Description and Business Overview
 Table 69. Novartis Immuno-Oncology Product
 Table 70. Novartis Immuno-Oncology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Novartis Revenue Proportion of Immuno-Oncology by Product in 2024
 Table 72. Novartis Revenue Proportion of Immuno-Oncology by Application in 2024
 Table 73. Novartis Revenue Proportion of Immuno-Oncology by Geographic Area in 2024
 Table 74. Novartis Recent Developments
 Table 75. Gilead Sciences Inc. Corporation Information
 Table 76. Gilead Sciences Inc. Description and Business Overview
 Table 77. Gilead Sciences Inc. Immuno-Oncology Product
 Table 78. Gilead Sciences Inc. Immuno-Oncology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Gilead Sciences Inc. Revenue Proportion of Immuno-Oncology by Product in 2024
 Table 80. Gilead Sciences Inc. Revenue Proportion of Immuno-Oncology by Application in 2024
 Table 81. Gilead Sciences Inc. Revenue Proportion of Immuno-Oncology by Geographic Area in 2024
 Table 82. Gilead Sciences Inc. Recent Developments
 Table 83. Merck KGaA Corporation Information
 Table 84. Merck KGaA Description and Business Overview
 Table 85. Merck KGaA Immuno-Oncology Product
 Table 86. Merck KGaA Immuno-Oncology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Merck KGaA Revenue Proportion of Immuno-Oncology by Product in 2024
 Table 88. Merck KGaA Revenue Proportion of Immuno-Oncology by Application in 2024
 Table 89. Merck KGaA Revenue Proportion of Immuno-Oncology by Geographic Area in 2024
 Table 90. Merck KGaA Recent Developments
 Table 91. North America Immuno-Oncology Revenue by Country (2020-2025) & (US$ Million)
 Table 92. North America Immuno-Oncology Revenue by Country (2026-2031) & (US$ Million)
 Table 93. North America Immuno-Oncology Revenue by Type (2020-2025) & (US$ Million)
 Table 94. North America Immuno-Oncology Revenue by Application (2020-2025) & (US$ Million)
 Table 95. Asia-Pacific Immuno-Oncology Revenue by Region (2020-2025) & (US$ Million)
 Table 96. Asia-Pacific Immuno-Oncology Revenue by Region (2026-2031) & (US$ Million)
 Table 97. Asia-Pacific Immuno-Oncology Revenue by Type (2020-2025) & (US$ Million)
 Table 98. Asia-Pacific Immuno-Oncology Revenue by Application (2020-2025) & (US$ Million)
 Table 99. Europe Immuno-Oncology Revenue by Country (2020-2025) & (US$ Million)
 Table 100. Europe Immuno-Oncology Revenue by Country (2026-2031) & (US$ Million)
 Table 101. Europe Immuno-Oncology Revenue by Type (2020-2025) & (US$ Million)
 Table 102. Europe Immuno-Oncology Revenue by Application (2020-2025) & (US$ Million)
 Table 103. Latin America Immuno-Oncology Revenue by Country (2020-2025) & (US$ Million)
 Table 104. Latin America Immuno-Oncology Revenue by Country (2026-2031) & (US$ Million)
 Table 105. Latin America Immuno-Oncology Revenue by Type (2020-2025) & (US$ Million)
 Table 106. Latin America Immuno-Oncology Revenue by Application (2020-2025) & (US$ Million)
 Table 107. Middle East and Africa Immuno-Oncology Revenue by Country (2020-2025) & (US$ Million)
 Table 108. Middle East and Africa Immuno-Oncology Revenue by Country (2026-2031) & (US$ Million)
 Table 109. Middle East and Africa Immuno-Oncology Revenue by Type (2020-2025) & (US$ Million)
 Table 110. Middle East and Africa Immuno-Oncology Revenue by Application (2020-2025) & (US$ Million)
 Table 111. Immuno-Oncology Key Raw Materials, Industry Status and Trend
 Table 112. Immuno-Oncology Key Raw Materials and Upstream Suppliers
 Table 113. Immuno-Oncology Clients Status and Trend
 Table 114. Immuno-Oncology Typical Clients
 Table 115. Immuno-Oncology Distributors
 Table 116. Immuno-Oncology Market Trends
 Table 117. Immuno-Oncology Market Drivers
 Table 118. Immuno-Oncology Market Challenges
 Table 119. Immuno-Oncology Market Restraints
 Table 120. Research Programs/Design for This Report
 Table 121. Key Data Information from Secondary Sources
 Table 122. Key Data Information from Primary Sources


List of Figures
 Figure 1. Immuno-Oncology Product Picture
 Figure 2. Global Immuno-Oncology Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Immuno-Oncology Revenue Market Share by Type in 2024 & 2031
 Figure 4. Immune Checkpoint Inhibitors Product Picture
 Figure 5. Cytokine-Based Immunotherapy Product Picture
 Figure 6. Cancer Vaccines Product Picture
 Figure 7. CAR-T Cell Therapy Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Immuno-Oncology Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 10. Global Immuno-Oncology Revenue Market Share by Application in 2024 & 2031
 Figure 11. Hospitals
 Figure 12. Drugstores
 Figure 13. Others
 Figure 14. Immuno-Oncology Report Years Considered
 Figure 15. Global Immuno-Oncology Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Immuno-Oncology Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Immuno-Oncology Market Size Market Share by Region: 2024 Versus 2031
 Figure 18. Global Immuno-Oncology Revenue Market Share by Region (2020-2031)
 Figure 19. Global Immuno-Oncology Revenue Market Share Forecast by Type (2020-2031)
 Figure 20. Global Immuno-Oncology Revenue Market Share Forecast by Application (2020-2031)
 Figure 21. Immune Checkpoint Inhibitors of Immuno-Oncology Revenue Market Share by Application, 2024 VS 2031
 Figure 22. Cytokine-Based Immunotherapy of Immuno-Oncology Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Cancer Vaccines of Immuno-Oncology Revenue Market Share by Application, 2024 VS 2031
 Figure 24. CAR-T Cell Therapy of Immuno-Oncology Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Others of Immuno-Oncology Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Immuno-Oncology Revenue Share by Company (2024)
 Figure 27. Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 28. Immune Checkpoint Inhibitors Revenue Proportion by Company in 2024
 Figure 29. Cytokine-Based Immunotherapy Revenue Proportion by Company in 2024
 Figure 30. Cancer Vaccines Revenue Proportion by Company in 2024
 Figure 31. CAR-T Cell Therapy Revenue Proportion by Company in 2024
 Figure 32. Others Revenue Proportion by Company in 2024
 Figure 33. North America Immuno-Oncology Revenue 2020-2031 (US$ Million)
 Figure 34. North America Immuno-Oncology Revenue Market Share by Type (2020-2025)
 Figure 35. North America Immuno-Oncology Revenue Market Share by Application (2020-2025)
 Figure 36. Asia-Pacific Immuno-Oncology Revenue 2020-2031 (US$ Million)
 Figure 37. Asia-Pacific Immuno-Oncology Revenue Market Share by Region (2020-2031)
 Figure 38. Asia-Pacific Immuno-Oncology Revenue Market Share by Type (2020-2025)
 Figure 39. Asia-Pacific Immuno-Oncology Revenue Market Share by Application (2020-2025)
 Figure 40. Europe Immuno-Oncology Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 41. Europe Immuno-Oncology Revenue Market Share by Country (2020-2031)
 Figure 42. Europe Immuno-Oncology Revenue Market Share by Type (2020-2025)
 Figure 43. Europe Immuno-Oncology Revenue Market Share by Application (2020-2025)
 Figure 44. Latin America Immuno-Oncology Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 45. Latin America Immuno-Oncology Revenue Market Share by Country (2020-2031)
 Figure 46. Latin America Immuno-Oncology Revenue Market Share by Type (2020-2025)
 Figure 47. Latin America Immuno-Oncology Revenue Market Share by Application (2020-2025)
 Figure 48. Middle East and Africa Immuno-Oncology Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 49. Middle East and Africa Immuno-Oncology Revenue Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Immuno-Oncology Revenue Market Share by Type (2020-2025)
 Figure 51. Middle East and Africa Immuno-Oncology Revenue Market Share by Application (2020-2025)
 Figure 52. Immuno-Oncology Supply Chain (Upstream and Downstream Market)
 Figure 53. Global Production Market Share of Immuno-Oncology Raw Materials by Region in 2024
 Figure 54. Immuno-Oncology Distribution Channels
 Figure 55. Global Immuno-Oncology Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 56. Global Immuno-Oncology Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Oncology Immuno Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Immunotherapy Market
Global Immuno Oncology Service Market Research Report 2024
Global Immuno oncology Therapy Market Insights Forecast to 2030
Immuno Oncology Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immuno oncology Clinical Trials Market Research Report 2024
Immuno oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immuno Oncology Assays Kit Market Insights Forecast to 2030
Global Immuno Oncology Treatment Market Insights Forecast to 2030
Global Immunotherapy Drugs Market Research Report 2024
AI In Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Immuno Personalized Medicine Market Research Report 2024
Global Oncology EMR Software Market Insights Forecast to 2030
Immuno oncology Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncology Small Molecule Drugs Market Insights Forecast to 2030
Global Immuno Cell Therapy Market Research Report 2024
Global Cancer Immunotherapy Drugs Market Research Report 2024
Global Immunosuppressants in Cancer Therapy Market Research Report 2024
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights Forecast to 2030
Global Cancer Immunosuppressant Treatment Market Research Report 2024

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q6174
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29V19536
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions